Laboratory leaders should prepare now for the end of the federal public health emergency (PHE) for SARS-CoV-2. The White House announced the PHE would cease on May 11. One big change is that patients covered by Medicare, Medicaid, or private insurance may pay higher costs for COVID-19 treatment, including some diagnostic laboratory tests. If patients …
February 13, 2023, Intelligence: Late-Breaking Lab News Read More »
